NO20001273D0 - Immunanalyse for BNP - Google Patents

Immunanalyse for BNP

Info

Publication number
NO20001273D0
NO20001273D0 NO20001273A NO20001273A NO20001273D0 NO 20001273 D0 NO20001273 D0 NO 20001273D0 NO 20001273 A NO20001273 A NO 20001273A NO 20001273 A NO20001273 A NO 20001273A NO 20001273 D0 NO20001273 D0 NO 20001273D0
Authority
NO
Norway
Prior art keywords
bnp
gdp
mammalian
immune analysis
gamma
Prior art date
Application number
NO20001273A
Other languages
English (en)
Other versions
NO325020B1 (no
NO20001273L (no
Inventor
Hidehisa Asada
Hiroyuki Shimizu
Kazuaki Endou
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17152093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20001273(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20001273D0 publication Critical patent/NO20001273D0/no
Publication of NO20001273L publication Critical patent/NO20001273L/no
Publication of NO325020B1 publication Critical patent/NO325020B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO20001273A 1997-09-11 2000-03-10 Immunanalyse som er spesifikk for pattedyr-gamma-BNP-derivater samt sett NO325020B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24668497 1997-09-11
PCT/JP1998/004063 WO1999013331A1 (fr) 1997-09-11 1998-09-10 Procede de dosage immunologique pour bnp

Publications (3)

Publication Number Publication Date
NO20001273D0 true NO20001273D0 (no) 2000-03-10
NO20001273L NO20001273L (no) 2000-05-10
NO325020B1 NO325020B1 (no) 2008-01-14

Family

ID=17152093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001273A NO325020B1 (no) 1997-09-11 2000-03-10 Immunanalyse som er spesifikk for pattedyr-gamma-BNP-derivater samt sett

Country Status (13)

Country Link
US (1) US6828107B2 (no)
EP (1) EP1016867B1 (no)
JP (1) JP3516655B2 (no)
KR (1) KR100563358B1 (no)
CN (1) CN1161609C (no)
AT (1) ATE315228T1 (no)
AU (1) AU731858B2 (no)
CA (1) CA2304263C (no)
DE (1) DE69833118T2 (no)
DK (1) DK1016867T3 (no)
ES (1) ES2256952T3 (no)
NO (1) NO325020B1 (no)
WO (1) WO1999013331A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
JP2005522669A (ja) * 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3691803B2 (ja) * 2002-03-14 2005-09-07 三洋化成工業株式会社 血液中の心不全マーカー定量方法
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
ES2573471T3 (es) 2002-05-09 2016-06-08 The Brigham And Women's Hospital, Inc. 1L1RL-1 como un marcador de enfermedades cardiovasculares
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US7135329B2 (en) * 2002-11-18 2006-11-14 Princeton Biomeditech Corporation Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
JP4881156B2 (ja) 2003-06-20 2012-02-22 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 脳性ナトリウム利尿ペプチドのアイソフォーム
JP2007525213A (ja) * 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
US20080182299A1 (en) * 2004-01-27 2008-07-31 Compugent Ltd. Novel brain natriuretic peptide variants and methods of use thereof
WO2005089045A2 (en) * 2004-03-19 2005-09-29 Universite Catholique De Louvain Prognostic methods for congestive heart failure
AT500800B1 (de) 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
US20060051825A1 (en) * 2004-09-09 2006-03-09 Buechler Kenneth F Methods and compositions for measuring canine BNP and uses thereof
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
US20070207152A1 (en) 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
US7998683B2 (en) 2006-04-24 2011-08-16 Critical Care Diagnostics, Inc. Predicting mortality and detecting severe disease
HUE028594T2 (en) * 2006-05-01 2016-12-28 Critical Care Diagnostics Inc Diagnosis of cardiovascular disease
WO2008021872A1 (en) * 2006-08-08 2008-02-21 Mayo Foundation For Medical Education And Research Diuretic and natriuretic polypeptides
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
WO2008095052A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
EP2150811B1 (en) * 2007-05-08 2013-01-16 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
WO2009036448A2 (en) * 2007-09-15 2009-03-19 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-c agonists
WO2009086126A2 (en) * 2007-12-21 2009-07-09 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
ES2590213T3 (es) 2008-04-18 2016-11-18 Critical Care Diagnostics, Inc. Predicción del riesgo a sufrir episodios cardíacos adversos graves
EP3875137B1 (en) 2008-06-02 2023-12-20 Loma Vista Medical, Inc. Inflatable medical devices
US20110270530A1 (en) * 2008-12-08 2011-11-03 Seok-Won Lee Combined natriuretic peptide assays
CN101923090A (zh) * 2009-06-10 2010-12-22 中国科学院电子学研究所 固定人体脑钠肽的光学敏感膜的制备方法
EP3552655B1 (en) 2010-07-13 2020-12-23 Loma Vista Medical, Inc. Inflatable medical devices
US8778699B2 (en) 2010-08-04 2014-07-15 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
CA2856798A1 (en) 2011-05-31 2012-12-06 Idexx Laboratories, Inc. Detection of degradation products of feline nt-probnp
CN107090028A (zh) 2011-08-30 2017-08-25 梅约医学教育与研究基金会 利钠多肽
WO2013103896A1 (en) 2012-01-06 2013-07-11 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
EP2888687B1 (en) 2012-08-21 2023-08-02 Critical Care Diagnostics, Inc. Multimarker risk stratification
CN112710852B (zh) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 一种gnp多肽的检测试剂盒及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
DE69833118T2 (de) 2006-08-31
US6828107B2 (en) 2004-12-07
NO325020B1 (no) 2008-01-14
KR100563358B1 (ko) 2006-03-22
AU9001098A (en) 1999-03-29
DK1016867T3 (da) 2006-05-22
ES2256952T3 (es) 2006-07-16
DE69833118D1 (de) 2006-03-30
CA2304263A1 (en) 1999-03-18
EP1016867B1 (en) 2006-01-04
CN1161609C (zh) 2004-08-11
US20030157596A1 (en) 2003-08-21
EP1016867A4 (en) 2004-11-17
ATE315228T1 (de) 2006-02-15
EP1016867A1 (en) 2000-07-05
AU731858B2 (en) 2001-04-05
NO20001273L (no) 2000-05-10
KR20010023853A (ko) 2001-03-26
CN1278919A (zh) 2001-01-03
WO1999013331A1 (fr) 1999-03-18
JP3516655B2 (ja) 2004-04-05
CA2304263C (en) 2008-07-29

Similar Documents

Publication Publication Date Title
NO20001273D0 (no) Immunanalyse for BNP
ES2151528T3 (es) Composicion de calibrador o control para un ensayo de serologia igm.
DE3579841D1 (de) Multisites immunometrisches testverfahren.
BR9906351A (pt) Método para ensaio de anticorpos e dispositivo de ensaio de anticorpo
ES2194139T3 (es) Aumento de la sensibilidad en la determinacion inmunoquimica de un analito.
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
EP0829723A3 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
ES2101959T3 (es) Procedimiento para llevar a cabo un ensayo inmunologico utilizando la espectroscopia de desviacion fototermica.
ES2094784T3 (es) Procedimiento para la determinacion de un analito.
ES2061881T3 (es) Procedimiento para la determinacion de anticuerpos especificos de la clase de un antigeno asi como un reactivo apropiado para ello.
DE59606685D1 (de) Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
KR900016464A (ko) Anp의 c-말단을 인식하는 단클론성 항체
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
AU3326989A (en) Immunoassay for the detection of alpha-haloacetamides
EP0757250A4 (en) ASSAY METHOD FOR THE ASIALOGLYCOPROTEIN RECEPTOR AND ASSAY REAGENT PROVIDED THEREFOR
FI860936A (fi) Menetelmä ja reagenssi luteinisoivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
DE69727975D1 (de) 5-hydroxytryptophol (5-htol) derivate, antikörper, immunoassays und detektion von kürzfristigem alkoholkonsum
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6
CA2110019A1 (en) Immunoassays for determining vitamin b12, and reagents and kits therefor
SE9900875D0 (sv) Antinuclear antibody assay utilizing stress-treated cells or cell extracts

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees